Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Discover the effectiveness and safety of Mounjaro, the new weight loss drug launched in India. Learn from expert Dr. Pal ...

Eli Lilly's Mounjaro enters Indian market, triggering a sharp rise in consultations as obesity rates climb and patients seek more accessible treatment options ...

Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

The India launch of Eli Lilly’s popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...

Representative image India’s anti-obesity drug market has ... Advt The recent launch of Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes ...

Obesity is driving up rates of type 2 diabetes, hypertension, heart disease, fatty liver, sleep apnoea, and even cancers. A ...

India’s generic drugmakers are also racing ... Zepbound, which has the same active ingredient, tirzepatide, is the brand name for the US weight loss version, with Mounjaro sold for diabetes ...